리센스메디컬

394420KOSDAQView the 의료·정밀기기 sectorTheme Bio & healthcare

5,780KRWMarket close of 10/26 (Mon)

Down -8.40%-530KRWMarket close of 10/26 (Mon)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/27 (Tue)5,470KRWDown -5.36%

Preliminary · replaced once official KRX data for the same date is published

Open
6,120
High
6,660
Low
5,780
Day range
Day range low 5,780 high 6,660, open 6,120, close 5,780, previous close 6,310
Volume
10×10K shares
586.70 million KRW 0.79× the 20-session average

Market close of 10/26 (Mon)

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/26 (Mon)
Market close data of 2026-10-26

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move-8.40%usual range
  • Trading value0.8×usual range

With 139 trading days, the 1-year position isn't calculated · First data date 3/31 (Tue)

See the full check report

Quarterly results ·

Quarterly operating income trend

As of the latest official close · 2026-10-26Valuation filing date · 2026-08-14

Same sector · 의료·정밀기기

Down -2.32%

· 27 of 101 stocks up, preferred shares excluded · trading value 195.4B KRW

Same sector · top by trading value
Stock20DChangeTrading value
씨어스Close over the last 20 sessions +8.8%Up +17.51%31.2B KRW
빅텍Close over the last 20 sessions +6.2%Down -19.29%28.8B KRW
디아이Close over the last 20 sessions +3.7%Down -3.35%18.1B KRW
티에스이Close over the last 20 sessions -14.2%Down -6.23%16.6B KRW
케이씨텍Close over the last 20 sessions +7.2%Down -8.67%11.7B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 19 days
  • Next data 10/28 (Wed) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 80% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.